Avanos Medical (Avanos Medical) Long-Term Capital Lease Obligation : $26.6 Mil (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Avanos Medical Long-Term Capital Lease Obligation?

Avanos Medical's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was $26.6 Mil.

Avanos Medical's quarterly Long-Term Capital Lease Obligation declined from Sep. 2023 ($29.5 Mil) to Dec. 2023 ($28.3 Mil) and declined from Dec. 2023 ($28.3 Mil) to Mar. 2024 ($26.6 Mil).

Avanos Medical's annual Long-Term Capital Lease Obligation declined from Dec. 2021 ($42.8 Mil) to Dec. 2022 ($32.5 Mil) and declined from Dec. 2022 ($32.5 Mil) to Dec. 2023 ($28.3 Mil).

Avanos Medical Long-Term Capital Lease Obligation Historical Data

The historical data trend for Avanos Medical's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avanos Medical Long-Term Capital Lease Obligation Chart

Avanos Medical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

62.60

53.30

42.80

32.50

28.30

Avanos Medical Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															32.40	30.90	29.50	28.30	26.60

Avanos Medical (NYSE:AVNS) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Avanos Medical Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Avanos Medical's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Avanos Medical (Avanos Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Avanos Medical Inc (NYSE:AVNS) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

8HH:Germany

Address

5405 Windward Parkway, Suite 100 South, Alpharetta, GA, USA, 30004

Website

https://www.avanos.com

Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. The firm operates in one segment, medical devices, which primarily sells products related to pain management, IV Therapy, and respiratory and digestive health. The company divides its Medical Devices segment into two franchises: Pain Management and Chronic Care. Pain Management provides non-opioid products for acute and interventional pain, including cold and compression therapy. Chronic Care aims at addressing digestive and respiratory issues with feeding tubes and catheters. Avanos generates most of its revenue from its Chronic Care franchise and in North America.

Executives

Sudhakar Varshney	officer: SVP, Global Supply Chain	5405 WINDWARD PARKWAY, SUITE 100 SOUTH, ALPHARETTA GA 30004
Lisa Egbuonu-davis	director	C/O OMEGA HEALTHCARE INVESTORS, INC., 303 INTERNATIONAL CIRCLE, SUITE 200, HUNT VALLEY MD 21030
John Joseph Hurley	officer: Principal Accounting Officer	5405 WINDWARD PARKWAY, ALPHARETTA GA 30004
Patrick J Oleary	director	31515 BALLANTYNE CORP, C/O SPX CORP, CHARLOTTE NC 28277
Mojirade James	officer: SVP, General Counsel	5405 WINDWARD PKWY, ALPHARETTA GA 30004
Kerr Holbrook	officer: SVP, GM Chronic Care	5405 WINDWARD PKWY, ALPHARETTA GA 30004
Michael Greiner	officer: SVP - Chief Financial Officer	C/O VISTAPRINT, 95 HAYDEN AVENUE, LEXINGTON MA 02421
David Edward Ball	officer: SVP - Global Supply Chain	AVANOS MEDICAL, INC., 5405 WINDWARD PKWY, ALPHARETTA GA 30004
William David Haydon	officer: SVP, GM Pain Franchise	5405 WINDWARD PARKWAY, ALPHARETTA GA 30004
Arjun Ranjan Sarker	officer: Senior VP, International	HALYARD HEALTH, INC., 5405 WINDWARD PARKWAY, ALPHARETTA GA 30004
Gary Blackford	director	7700 FRANCE AVENUE SOUTH, EDINA MN 55435
Joseph Fralin Woody	director, officer: Chief Executive Officer	5405 WINDWARD PARKWAY, SUITE 100 SOUTH, ALPHARETTA GA 30004
Steven E Voskuil	officer: See Remarks	5405 WINDWARD PARKWAY, ALPHARETTA GA 30004
John W Wesley	director	5405 WINDWARD PARKWAY, ALPHARETTA GA 30004
John Raymond Tushar	officer: President, Global Franchises	HALYARD HEALTH, INC., 5405 WINDWARD PARKWAY, ALPHARETTA GA 30004